about
Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis CInvestigation of Putative Multisubtype Hepatitis C Virus Infections In Vivo by Heteroduplex Mobility Analysis of Core/Envelope SubgenomesInfection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death.Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose.Epidemiology of Invasive Group A Streptococcal Disease in Alaska, 2001 to 2013.Risk Factors for Pneumococcal Colonization of the Nasopharynx in Alaska Native Adults and Children.Migration of persons between households in rural Alaska: considerations for study design.Treatment eligibility in Alaska Native and American Indian persons with hepatitis C virus infection.Diagnostic accuracy of tests for Helicobacter pylori in an Alaska Native population.Invasive pneumococcal disease in Alaskan children: impact of the seven-valent pneumococcal conjugate vaccine and the role of water supply.International Circumpolar Surveillance System for invasive pneumococcal disease, 1999-20052009 Pandemic influenza A H1N1 in Alaska: temporal and geographic characteristics of spread and increased risk of hospitalization among Alaska Native and Asian/Pacific Islander people.Molecular characterization of Streptococcus pneumoniae serotype 12F isolates associated with rural community outbreaks in AlaskaWasheteria closures, infectious disease and community health in rural Alaska: a review of clinical data in Kivalina, Alaska.Evaluation of seaFAST, a rapid fluorescent in situ hybridization test, for detection of Helicobacter pylori and resistance to clarithromycin in paraffin-embedded biopsy sectionsHigh rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives.Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C.Methicillin-Resistant Staphylococcus aureus carriage and risk factors for skin infections, Southwestern Alaska, USA.Characterizing wild bird contact and seropositivity to highly pathogenic avian influenza A (H5N1) virus in Alaskan residents.Characterization of Helicobacter pylori cagA and vacA genotypes among Alaskans and their correlation with clinical disease.Alaska sentinel surveillance study of Helicobacter pylori isolates from Alaska Native persons from 2000 to 2008Dynamics of Helicobacter pylori-specific immunoglobulin G for 2 years after successful eradication of Helicobacter pylori infection in an American Indian and Alaska Native population.The effect of Helicobacter pylori infection on iron stores and iron deficiency in urban Alaska Native adultsHaemophilus influenzae serotype a invasive disease, Alaska, USA, 1983-2011.Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study.Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska.Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity.Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska.PCV7-induced changes in pneumococcal carriage and invasive disease burden in Alaskan children.Epidemiology and risk factors for hepatitis C in Alaska Natives.Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis C infection.Hepatitis C infection in Alaska Natives with persistently normal, persistently elevated or fluctuating alanine aminotransferase levels.Hepatitis C virus dynamics during natural infection are associated with long-term histological outcome of chronic hepatitis C disease.Epidemiology of pneumococcal serotype 6A and 6C among invasive and carriage isolates from Alaska, 1986-2009.Viral respiratory infections in hospitalized and community control children in Alaska.Steatosis and hepatitis C in an Alaska Native/American Indian population.Effect of high-dose amoxicillin on the prevalence of penicillin-resistant Streptococcus pneumoniae in rural Alaska.An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska.Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children.Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.
P50
Q27486537-D1400D83-F1D6-470D-9BF2-E3BABD4B82A8Q27486577-BC5D64A2-D7CA-431B-9E00-5599F4912C62Q30151690-7EBFD7BA-218C-4653-BAA6-6261977F0630Q30196893-1368729E-E276-47EC-8DE9-3F1A83C64D7DQ30202103-771925CD-3F16-46F0-AAFA-4AE9DB0BBC90Q30209978-356ECD01-067A-4BB1-BB67-2800A87D43C7Q30220944-225447E8-1DDA-4835-82BB-4E2AAD10755FQ30224806-5BE15861-2C34-4420-84F1-F835BFDE2406Q30224839-BD467FB0-9ADD-470D-89D3-1A82773E8132Q30227407-04F38754-C71D-461B-9378-131D822ED4E5Q30229113-0E700EF2-0831-4E6C-959C-296F59C506B9Q30400020-76D43FBA-FC50-4B04-BE33-A697CE49CF69Q30539635-1A91F06D-D7FC-42D4-AF45-F428A0D0304AQ30663893-CB8996AE-2830-4EDF-93F8-5C57D21878E9Q33884860-9A12FAF4-1EB3-4C21-A1F7-E6D4D27121B7Q33993892-C6F60ECC-B47D-4BCB-8714-D267A321217EQ34053331-94167B87-9FB9-4165-822F-C4FA0887D5D0Q34194012-26CB6404-D056-440B-B0C8-AE4D4221A6F2Q34274896-836EA9E4-C06F-40BC-88D3-971A534F2FB0Q35192162-3F1649FB-9429-4B30-8217-57FFDE4F2774Q35273580-76D58C0F-E8AE-4B85-BAE1-61F5D1946768Q35635843-45FDA351-0079-404B-A67D-4BE62D221A59Q36045719-EC88CDD2-69DA-4C1E-A124-E4F0A2A21705Q37020548-630FF4FC-D5D7-4702-BAA2-DD7A7C90CE36Q38687853-4EE07195-81CD-462F-B4D2-EFC4C974132BQ39699700-14381D93-1B2A-4048-8F3A-C29486D4113EQ39731338-E6E38149-A8B1-4656-B03F-84AF592C25C8Q41069257-08279A0C-D287-428D-9FE8-FE49FED6DA1CQ41721412-0CCAF302-2401-4A60-B6AF-14E07003F684Q42982924-F47EE234-CC97-40DD-859A-0EC632F10D75Q42992687-6B54E11B-CB0F-4F71-B3FA-EC70849A7AF5Q43001259-A9252B3C-6349-4459-8ABB-EA58E78FB5F8Q43038486-91642BFB-19B4-42F2-98C7-6D3CF3F7BEC4Q43192562-9178F279-D1DA-4105-84A7-19E5BD512274Q43439849-46C1428C-73C7-40C7-BD7E-32368A3A42C5Q43781297-683F76C0-BD86-42B0-9771-7479C9930A47Q43967024-D9BF36CB-152E-438D-B85A-21592704541CQ44163434-825018C8-DA8C-4009-8B39-A902230BA59CQ44259087-83DA656E-F18E-4ACE-BC4B-0D935C3A5259Q44581239-BE22476B-F493-42A7-B82F-4D5FD4D7A541
P50
name
Dana L Bruden
@ast
Dana L Bruden
@en
Dana L Bruden
@nl
type
label
Dana L Bruden
@ast
Dana L Bruden
@en
Dana L Bruden
@nl
prefLabel
Dana L Bruden
@ast
Dana L Bruden
@en
Dana L Bruden
@nl